A local, one time, low-dose injection of ZOL at the site of implantation is able to promote the osseointegration of Ti implants following postmenopausal osteoporosis, and this action may be partly mediated by inhibition of the osteoporosis-induced AGE overproduction in the bone marrow.
No takes yet. Share an insight, caveat, or question.
Ying et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: